Advertisement

Topics

CarboGen Laboratories Company Profile

18:22 EDT 25th September 2017 | BioPortfolio

Faster-to-Market is the top priority of research-based pharmaceutical companies. CarboGen is a company that specializes in helping these companies accomplish this. For the last ten years CarboGen has focused exclusively on providing its partners with the capabilities to obtain rapid clinical batches of API. This includes process research for synthetic route finding and feasibility testing, analytical control at every stage of early drug development, process optimization for subsequent industrial scale-up, and the technology transfer of these processes to the chosen commercial manufacturer.

All together, CarboGen’s three separate facilities employ 200 chemists, of which 85 have a Ph.D. in either organic or analytical chemistry. The average level of education at CarboGen is therefore very high. The result is science, speed, and quality.

CarboGen is committed to quality. ISO 9001 standards were implemented as early as 1991; ISO 14001 certification is scheduled for 2000. With a total of 15 bench labs (105 hoods) and 36 reactors (16 l to 640 l), CarboGen has the flexibility to work on your project when you need it.

CarboGen adheres to the strictest standards of confidentiality and shares the know-how that is acquired during a project only with the corresponding partner.

CarboGen is part of the Solutia group since February, 2000.

The CarboGen team looks forward to helping you go faster to market. If you have any questions or would like to know more about CarboGen, call on +41 (62) 822 73 00, or visit our Web site at www.carbogen.com.

Contacts:

Dieter Beer, Ph.D: President & CEO

Matthias Kuratli, Ph.D: COO

Frank Kumli, Ph.D: Sales Manager

Location

Schachenallee 29
Aarau
CH-5001
Switzerland

Contact

Phone: +41628227300
Fax: +41628227310


News Articles [348 Associated News Articles listed on BioPortfolio]

Swiss pharma company successfully completes inspections at three sites

CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and API manufacturing company, has successfully completed Swissmedic inspections at three of its sites, resulting in the renewal ...

Contrasting IDEXX Laboratories

IDEXX Laboratories and Heska Corporation are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, di...

Enterome to move its research laboratories

Enterome, a pioneer of innovative therapies for microbiome-related diseases announced that the Company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology ...

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will...

Wall Street analysts forecast that Impax Laboratories Inc will post $196.18 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Impax Laboratories'...

Analyzing Impax Laboratories

Pfizer and Impax Laboratories are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional owner...

$0.14 EPS Expected for Impax Laboratories, Inc. (IPXL) This Quarter

Analysts expect Impax Laboratories, Inc. to report earnings per share of $0.14 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Impax Laboratories' ea...

Zacks: Analysts Anticipate Impax Laboratories Inc (IPXL) to Announce $0.13 EPS

Equities analysts expect that Impax Laboratories Inc will post earnings per share of $0.13 for the current quarter, according to Zacks Investment Research . Four analysts have made estimates for Impax...

Morning Stock Stories: Impax Laboratories, Inc.

With a market cap of 1.21B, Impax Laboratories, Inc. has a large market cap size. Impax Laboratories, Inc. has been on the stock market since its IPO date on the 12/19/1995.

PubMed Articles [194 Associated PubMed Articles listed on BioPortfolio]

Project management: importance for diagnostic laboratories.

The constraints applied on diagnostic laboratories to improve both quality and productivity together with personal shortages incite laboratory managers to constantly optimize the laboratory workflows,...

Cancer incidence in female laboratory employees: extended follow-up of a Swedish cohort study.

Work in chemical laboratories is associated with exposure to chemicals, of which some are known or suspected carcinogens. A cohort study of laboratory workers in Stockholm followed until 1992 showed a...

This Is not Participatory Design - A Critical Analysis of Eight Living Laboratories.

Design of Health Technology for elderly and care personnel has a high priority because of a severe increase of elderly citizens in need of health care combined with a decrease of resources in the heal...

Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories.

Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisions for both physicians and patients. Most uncovered variants are benign, and determining which few a...

CLSI-Based Validation of Manufacturer-Derived Reference Intervals on the Cobas 8000 Platform.

Reference intervals provided by diagnostic test manufacturers should be transferred to clinical laboratories after validation. Although protocols exist, laboratories rarely perform and report on resul...

Clinical Trials [233 Associated Clinical Trials listed on BioPortfolio]

Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as carbogen and niacinamide may make tumor cells more sensitive to radiation therapy. It is not yet k...

Randomized Trial of ARCON in Larynx Cancer

TITLE: A multicentre, randomised, phase III clinical trial comparing accelerated radiotherapy with accelerated radiotherapy plus carbogen and nicotinamide (ARCON) in clinical stage T2-4 ...

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Companies [934 Associated Companies listed on BioPortfolio]

CarboGen Laboratories

Faster-to-Market is the top priority of research-based pharmaceutical companies. CarboGen is a company that specializes in helping these companies accomplish this. For the last ten years CarboGen has ...

CarboGen and AMCIS

CarboGen and AMCIS, recognized as world leaders in the development chemistry market, combine world-class chemistry skills to provide seamless drug substance development and commercialization services....

CARBOGEN AMCIS AG

CARBOGEN AMCIS, recognized as world leader in the development chemistry market, provides world-class chemistry skills to provide seamless drug substance development and commercialization services. D...

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

Rainbow Scientific, Inc.

Rainbow Scientific, Inc. markets, sells, and distributes state-of-the-art medical diagnostic test kits to both research and clinical laboratories. From our Windsor, Connecticut location, we are commit...

More Information about "CarboGen Laboratories" on BioPortfolio

We have published hundreds of CarboGen Laboratories news stories on BioPortfolio along with dozens of CarboGen Laboratories Clinical Trials and PubMed Articles about CarboGen Laboratories for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CarboGen Laboratories Companies in our database. You can also find out about relevant CarboGen Laboratories Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record